Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
4 hedge funds and large institutions have $16K invested in Aoxing Pharmaceutical Company Inc. in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
43% less capital invested
Capital invested by funds: $28K → $16K (-$12K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$261 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.87K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$353 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $8K | -$2.87K | -7,354 | -22% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $4K | -$353 | -906 | -7% |
|
|
EWM
3
Evercore Wealth Management
New York
| $4K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4K | -10,328 | Closed |
|
|
U
5
UBS
Zurich,
Switzerland
| – | +$261 | +669 | New |
|
AXN Hedge Fund Activity: Q2 2014 in Review
4 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q2 2014, worth a combined $16K — down 43% from $28K a quarter earlier.
Fund positioning in AXN was balanced in Q2 2014: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $261. The largest seller was Susquehanna International Group, exiting entirely with an estimated $4K sold.
- 4 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $16K of Aoxing Pharmaceutical Company Inc. stock for Q2 2014, down 43% quarter-over-quarter.
- 1 fund opened new Aoxing Pharmaceutical Company Inc. positions in Q2 2014 and 1 closed out, a net change of 0 holders.
- The largest Aoxing Pharmaceutical Company Inc. buyer in Q2 2014 was UBS, an estimated $261 added.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q2 2014 was Susquehanna International Group, an estimated $4K sold.
Based on aggregated 13F filings for Q2 2014.